CardioGenics Announces Schedule for Beta-Site Test
Post# of 301275
Posted On: 07/10/2013 9:30:03 AM
CardioGenics Announces Schedule for Beta-Site Testing MISSISSAUGA, Ontario, July 10, 2013 (GLOBE NEWSWIRE) -- CardioGenics Holdings Inc. (OTCBB:CGNH), developer of the ultra-sensitive QL Care™ analyzer, an immunoassay Point-Of-Care analyzer, and other products for the
(0)
(0)Scroll down for more posts ▼